Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

L-theanine for stress and cognition

Kamren Hall
Meds
December 22, 2025
Share
Tweet
Share

As a medical student, I’ve seen firsthand how stress and cognitive overload can wear people down, both in patients and in myself. During one particularly difficult exam block, a friend casually mentioned L-theanine, a supplement found in green tea, that supposedly helps with focus and calm. That got me curious: Was this just hype, or is there actually something to it?

So I took a closer look at the research.

L-theanine is a non-protein amino acid found primarily in the leaves of the green tea plant, Camellia sinensis. It’s long been valued in Japan and China for its calming properties. Today, it’s widely available in capsule or tablet form and marketed for its potential to reduce stress, improve cognition, and support better sleep. While a cup of green tea contains only 8 to 30 milligrams, supplements usually offer 100 to 400 milligrams per day, as shown in one study.

L-theanine appears to work through several neurotransmitter systems. Research suggests it acts as a glutamate reuptake inhibitor and a low-affinity glutamate receptor antagonist in the hippocampus, while also modulating GABA-A receptors. These mechanisms may explain both its calming and neuroprotective effects, according to a systematic review. Brain wave studies also show that L-theanine increases alpha wave activity, which is associated with relaxed but alert mental states (similar to the patterns seen in people resting with their eyes closed, as described by researchers). These changes appear as early as 45 minutes after ingestion and can last over an hour.

Clinical data supports its use for stress-related symptoms and mild cognitive enhancement. In a randomized, double-blind, placebo-controlled crossover study found that 30 healthy adults taking 200 mg of L-theanine daily for four weeks. They found significant improvements in scores on the Self-Rating Depression Scale, State-Trait Anxiety Inventory, and the Pittsburgh Sleep Quality Index. The study also noted improvements in verbal fluency and executive function, especially in participants who started with lower baseline scores.

Additional studies have focused on how L-theanine influences brain wave patterns and attention. A study found that a 50 mg dose significantly increased alpha brain wave activity in healthy volunteers, with effects lasting over 105 minutes. This suggests that L-theanine may promote calm alertness rather than sedation (an ideal state for tasks that require sustained focus). Other researchers noted improvements in attention, reaction time, and working memory across several small trials, particularly when L-theanine was combined with caffeine. In a small study of five males with ADHD, the combination also improved attention and cognitive composite scores.

The recommended dose for cognitive and stress-related effects is around 200 mg per day, which is significantly higher than what’s found in tea. It’s also inexpensive, usually costing between ten and twenty dollars a month. In the trials I reviewed, it was generally well tolerated with no serious adverse effects reported. Mild side effects like headache, fatigue, or gastrointestinal upset were rare. There are no well-documented drug interactions, though caution is advised for patients on sedatives, stimulants, or psychiatric medications until more data is available. Pregnant individuals and those with severe psychiatric disorders should likely avoid it for now.

L-theanine certainly doesn’t have enough evidence to replace pharmacologic therapy for generalized anxiety or ADHD, but it might be a helpful addition in mild to moderate cases, or for patients who prefer non-pharmaceutical options. Behavioral interventions like cognitive behavioral therapy (CBT) offer excellent long-term outcomes for anxiety and attention disorders, but they can be hard to access or slow to take effect. L-theanine could offer a low-cost, low-risk alternative that fills the gap for patients not yet ready for prescription treatment.

More research is needed to understand long-term outcomes, since most studies are short-term and often involve small sample sizes. That said, it may be that this supplement is best used short-term (something longer studies could help clarify).

Based on what we know now, L-theanine seems to be a safe and reasonable option for people experiencing mild stress, cognitive fatigue, or sleep issues. I’d recommend it to patients looking for a non-pharmacologic option, especially those already interested in supplements or green tea. It’s not a cure, but it might be just enough to help someone feel a little clearer and calmer in their day-to-day life.

Kamren Hall is a medical student.

Prev

The political selectivity of medical freedom: a double standard

December 22, 2025 Kevin 0
…
Next

The blind men and the elephant: a parable for modern pain management

December 22, 2025 Kevin 2
…

Tagged as: Medical school

Post navigation

< Previous Post
The political selectivity of medical freedom: a double standard
Next Post >
The blind men and the elephant: a parable for modern pain management

ADVERTISEMENT

Related Posts

  • Making medicine my home

    Christina Stach
  • Moral injury in medical school

    Anonymous
  • Social media: Striking a balance for physicians and parents

    Dawn Baker, MD
  • Medical school and the science of sleep

    Sarah Murad
  • Skyrocketing medical school applications: the hidden costs and stress factors

    Jessica Lee, MD
  • Regulating social media’s effects on mental health

    Mohammed Umer Waris, MD

More in Meds

  • Oral Wegovy: the miracle and the mess of the new GLP-1 pill

    Shiv K. Goel, MD
  • U.S. opioid policy history: How politics replaced science in pain care

    Richard A. Lawhern, PhD & Stephen E. Nadeau, MD
  • How CAR-NK cancer therapy could be safer than CAR-T

    Cliff Dominy, PhD
  • Psychedelic-assisted therapy: science, safety, and regulation

    Muhamad Aly Rifai, MD
  • The anticoagulant evidence controversy: a whistleblower’s perspective

    David K. Cundiff, MD
  • Is tramadol really ineffective and risky?

    John A. Bumpus, PhD
  • Most Popular

  • Past Week

    • Health care as a human right vs. commodity: Resolving the paradox

      Timothy Lesaca, MD | Physician
    • My wife’s story: How DEA and CDC guidelines destroyed our golden years

      Monty Goddard & Richard A. Lawhern, PhD | Conditions
    • The gastroenterologist shortage: Why supply is falling behind demand

      Brian Hudes, MD | Physician
    • Why voicemail in outpatient care is failing patients and staff

      Dan Ouellet | Tech
    • Alex Pretti’s death: Why politics belongs in emergency medicine

      Marilyn McCullum, RN | Conditions
    • U.S. opioid policy history: How politics replaced science in pain care

      Richard A. Lawhern, PhD & Stephen E. Nadeau, MD | Meds
  • Past 6 Months

    • How environmental justice and health disparities connect to climate change

      Kaitlynn Esemaya, Alexis Thompson, Annique McLune, and Anamaria Ancheta | Policy
    • Will AI replace primary care physicians?

      P. Dileep Kumar, MD, MBA | Tech
    • A physician father on the Dobbs decision and reproductive rights

      Travis Walker, MD, MPH | Physician
    • What is the minority tax in medicine?

      Tharini Nagarkar and Maranda C. Ward, EdD, MPH | Education
    • Why the U.S. health care system is failing patients and physicians

      John C. Hagan III, MD | Policy
    • Alex Pretti: a physician’s open letter defending his legacy

      Mousson Berrouet, DO | Physician
  • Recent Posts

    • AI censorship threatens the lifeline of caregiver support [PODCAST]

      The Podcast by KevinMD | Podcast
    • Demedicalize dying: Why end-of-life care needs a spiritual reset

      Kevin Haselhorst, MD | Physician
    • Physician due process: Surviving the court of public opinion

      Muhamad Aly Rifai, MD | Physician
    • Spaced repetition in medicine: Why current apps fail clinicians

      Dr. Sunakshi Bhatia | Physician
    • When the doctor becomes the patient: a breast cancer diagnosis

      Sue Hwang, MD | Conditions
    • My journey with fibroids and hysterectomy: a patient’s perspective

      Sonya Linda Bynum | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Health care as a human right vs. commodity: Resolving the paradox

      Timothy Lesaca, MD | Physician
    • My wife’s story: How DEA and CDC guidelines destroyed our golden years

      Monty Goddard & Richard A. Lawhern, PhD | Conditions
    • The gastroenterologist shortage: Why supply is falling behind demand

      Brian Hudes, MD | Physician
    • Why voicemail in outpatient care is failing patients and staff

      Dan Ouellet | Tech
    • Alex Pretti’s death: Why politics belongs in emergency medicine

      Marilyn McCullum, RN | Conditions
    • U.S. opioid policy history: How politics replaced science in pain care

      Richard A. Lawhern, PhD & Stephen E. Nadeau, MD | Meds
  • Past 6 Months

    • How environmental justice and health disparities connect to climate change

      Kaitlynn Esemaya, Alexis Thompson, Annique McLune, and Anamaria Ancheta | Policy
    • Will AI replace primary care physicians?

      P. Dileep Kumar, MD, MBA | Tech
    • A physician father on the Dobbs decision and reproductive rights

      Travis Walker, MD, MPH | Physician
    • What is the minority tax in medicine?

      Tharini Nagarkar and Maranda C. Ward, EdD, MPH | Education
    • Why the U.S. health care system is failing patients and physicians

      John C. Hagan III, MD | Policy
    • Alex Pretti: a physician’s open letter defending his legacy

      Mousson Berrouet, DO | Physician
  • Recent Posts

    • AI censorship threatens the lifeline of caregiver support [PODCAST]

      The Podcast by KevinMD | Podcast
    • Demedicalize dying: Why end-of-life care needs a spiritual reset

      Kevin Haselhorst, MD | Physician
    • Physician due process: Surviving the court of public opinion

      Muhamad Aly Rifai, MD | Physician
    • Spaced repetition in medicine: Why current apps fail clinicians

      Dr. Sunakshi Bhatia | Physician
    • When the doctor becomes the patient: a breast cancer diagnosis

      Sue Hwang, MD | Conditions
    • My journey with fibroids and hysterectomy: a patient’s perspective

      Sonya Linda Bynum | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...